3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
4
Terminated
3
Withdrawn
1
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Colorectal Neoplasms
21
Squamous Cell Carcinoma of Head and Neck
16
Colonic Neoplasms
11
Rectal Neoplasms
8
Head and Neck Neoplasms
8
Neoplasm Metastasis
6
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
2
Esophageal Neoplasms
2
Chordoma
2
Breast Neoplasms
2
Unresectable Colorectal Cancer
1
Tongue Neoplasms
1
Thymoma
1
Solid Tumor, Adult
1
Solid Cancer
1
Skin Neoplasms
1
Rectal Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Noonan Syndrome
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Metastatic Colorectal Adenocarcinoma
1
Lymphoid Interstitial Pneumonia
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Laryngeal Diseases
1
Interventions
monalizumab
1
linrodostat
1
durvalumab
1
Surgical Flaps
1
Radiotherapy
1
Nivolumab
1
Fluorouracil
1
Docetaxel
1
Cisplatin
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Laryngeal Diseases
×
Cetuximab
×
Clear all
NCT04590963
2026-03-13
INTERLINK-1
AstraZeneca
Phase 3
Active not recruiting
370 enrolled
21 charts